Table 1.
Patient characteristics (n = 86)
| Characteristics | n | % |
|---|---|---|
| Total no. of patients | 86 | |
| Age, years | median 65 (range 31–96) | |
| Sex | ||
| Male/Female | 73/13 | 85%/15% |
| Performance status | ||
| 0–1/2–3 | 72/14 | 84%/16% |
| Site of primary tumor | ||
| Oropharyngeal/Hypopharyngeal | 51/35 | 59%/41% |
| TNM classification (UICC 2009) | ||
| T-stage | ||
| T1/T2/T3/T4 | 12/45/15/14 | 14%/53%/17%/16% |
| N-stage | ||
| N0/N1/N2/N3 | 21/14/47/4 | 24%/16%/55%/5% |
| Clinical stage | ||
| StageI/StageII/StageIII/StageIVa–b | 3/14/13/56 | 3%/16%/15%/66% |
| Value of pSUVmax | median 8.0 (range 1.7–25.7) | |
| Content of treatment | ||
| RT only/CCRT | 17/69 | 20%/80% |
| Described dose (Gy) | median 70 (range 60–74.4) | |
| Histology | ||
| Squamous cell carcinoma | 83 | 97% |
| Lymphoepithelial carcinoma | 2 | 2% |
| Carcinoma (NOS) | 1 | 1% |
Abbreviations: UICC, Union for International Cancer Control; pSUVmax, the maximum standardized uptake value of the primary site; RT, Radiotherapy; CCRT, Concurrent radiotherapy; NOS, not otherwise specified.